Merck & Co pulls out of Galapagos deals
This article was originally published in Scrip
Executive Summary
Merck & Co is ending its alliances with Belgium-based biotech firm Galapagos as "changes" in its early discovery strategy has required it to make "some challenging decisions", it said.